Sinusoidal Obstruction Syndrome (SOS)

Sinusoidal Obstruction Syndrome (SOS) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Sinusoidal Obstruction Syndrome
Classified under: Cardiovascular Diseases
Digestive System Diseases
Immune System Diseases
Wounds and Injuries
Indicated drugs: Defibrotide

Resolves to

Vocabularies

MeSHT577229ICD-10K76.5SNOMED CT197365004MedDRA10047216UMLSC0019156

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

5Clinical trialsPhase, status and sponsor resolved per trial

1Contraindicated drugDrugs whose labels contraindicate them in this condition

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Sinusoidal Obstruction Syndrome (SOS) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.